Literature DB >> 7419682

Effect of central nervous system dopaminergic activation on prolactin secretion in man: evidence for a common central defect in hyperprolactinemic patients with and without radiological signs of pituitary tumors.

P G Crosignani, C Ferrari, A Malinverni, C Barbieri, A M Mattei, R Caldara, M Rocchetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7419682     DOI： 10.1210/jcem-51-5-1068

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  8 in total

1.  Reduced number of natural killer cells in patients with pathological hyperprolactinemia.

Authors:  R Gerli; P Rambotti; I Nicoletti; S Orlandi; G Migliorati; C Riccardi
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

Review 2.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

3.  Nomifensine in hyperprolactinemic states.

Authors:  E E Müller; F Camanni; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

4.  Nomifensine-induced pregnancy in a hyperprolactinemic woman.

Authors:  A R Genazzani; V De Leo; F Camanni; E E Müller
Journal:  J Endocrinol Invest       Date:  1982 Mar-Apr       Impact factor: 4.256

Review 5.  Pituitary microadenomas: diagnostic and therapeutic trends.

Authors:  E M Grimes
Journal:  J Natl Med Assoc       Date:  1984-10       Impact factor: 1.798

6.  Multicentric experience on the acute effect of nomifensine in hyperprolactinemic women.

Authors:  F Minuto; A Barbarino; G Baviera; G Mazzocchi; L De Marinis; R Leonardi; D Bernasconi; E Menini; G Maira; C Anile
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

Review 7.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

8.  The inability of dynamic tests of prolactin and TSH secretion to differentiate between tumorous and non-tumorous hyperprolactinemia.

Authors:  R W Prescott; D G Johnston; P K Taylor; J Haigh; D R Weightman; K Hall; D B Cook
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.